Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery
Authors:
- Zhenhuan LiZLZhenhuan Li
- Kunmei SuKSKunmei Su
- Bowen ChengBCBowen Cheng
- Yanchao DengYDYanchao Deng
- 1 February 2010
- journal article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 342 (2) , 607-613
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mesoporous silica/apatite nanocomposite: Special synthesis route to control local drug deliveryActa Biomaterialia, 2008
- Effects of surface coating on the controlled release of vitamin B1 from mesoporous silica tabletsJournal of Controlled Release, 2007
- A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidineJournal of Solid State Chemistry, 2006
- Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surfaceMicroporous and Mesoporous Materials, 2005
- Fabrication of Uniform Magnetic Nanocomposite Spheres with a Magnetic Core/Mesoporous Silica Shell StructureJournal of the American Chemical Society, 2005
- Magnetic Nanotubes for Magnetic-Field-Assisted Bioseparation, Biointeraction, and Drug DeliveryJournal of the American Chemical Society, 2005
- PLGA/mesoporous silica hybrid structure for controlled drug releaseJournal of Controlled Release, 2004
- Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug deliveryJournal of Controlled Release, 2004
- Influence of pore size of MCM-41 matrices on drug delivery rateMicroporous and Mesoporous Materials, 2004
- MCM-41 Organic Modification as Drug Delivery Rate RegulatorChemistry of Materials, 2002